Rilzabrutinib for the adult participants with chronic ITP who have completed Phase 3 study in Japan

Trial Identifier: LTS19407
Sponsor: Sanofi
Start Date: October 2025
Primary Completion Date: November 2026
Study Completion Date: November 2026
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan, Ibaraki Tsuchiura, Ibaraki, Japan, 300-0028
Japan, Ishikawa Kanazawa-shi, Ishikawa, Japan, 920-8641
Japan, Saitama Iruma-gun, Saitama, Japan, 350-0495